Wegovy results pictures: what the evidence really looks like

You've found a photo that looks extraordinary — here's the context behind it

Say you've come across a striking before-and-after image: a side-by-side of someone who appears dramatically different after a year on Wegovy. It's striking precisely because it looks real, not digitally altered, not an advertisement. And it may well be genuine. The STEP 1 trial, published in the New England Journal of Medicine, enrolled 1,961 adults with obesity or overweight alongside a weight-related condition, running for 68 weeks. Average weight loss at the 2.4mg maintenance dose was around 15%, with around a third of participants losing 20% or more. Photographs of those individuals would look remarkable.

What a single image cannot show you is the dose trajectory that produced that result, the lifestyle changes running alongside it, or the point at which the person started to notice a real difference. Semaglutide is titrated gradually (starting at 0.25mg and increasing roughly every four weeks) and the early weeks often produce only modest changes. For the full picture of how that timeline unfolds, our Wegovy before-and-after guide sets out what different stages typically look like with more context than any single photo can provide.

Results also depend on factors entirely invisible in a photograph: starting BMI, any underlying metabolic conditions, how well the GI side effects were managed, and whether the person eventually reached 2.4mg. Someone who tolerated the titration well and reached maintenance quickly will look different at 12 months than someone who paused at a lower dose for a few extra weeks.

What a realistic three-month picture tends to show

Three months in is the point many people first notice visible changes, and the point when a lot of the photographs circulating online were taken. By 12 weeks, a person on the standard titration schedule is typically approaching or at the 1mg dose. The trial data across the STEP programme suggests weight loss at this stage is often in the range of 5–8% of starting body weight, though individual variation is wide.

For context on what that looks like in practice, three-month accounts can give a more grounded picture than standalone images. The visible changes at this stage tend to be most apparent around the face, abdomen and upper body. They are rarely the dramatic transformation the most-shared photographs depict, those tend to come from much later in treatment, or from individuals who had more weight to lose at the outset.

This matters because unrealistic expectations are one of the main reasons people become disheartened and stop treatment early. Wegovy's benefits, including the cardiovascular risk reduction now part of its UK licence, accumulate over time. A month-by-month account is more useful for expectation-setting than a single comparison image, which is why the first month deserves its own honest explanation.

Why female-specific accounts get searched more, and what the data says

Searches for female Wegovy results are among the most common in this topic area, and with reason: hormonal differences, menopausal status and body composition all influence how weight loss presents visually. The STEP 1 trial enrolled predominantly female participants (around 74%), so the headline figures broadly reflect female outcomes. Women in the trial lost an average of around 15.1% of body weight at 2.4mg.

What those results looked like visually depended on where participants carried weight to begin with. This is worth knowing before you compare your own early results to a photograph from someone with a very different starting point. Our clinical team (you can read more about their background on the clinical team page) reviews every case individually, partly because the experience of treatment, and what progress looks like, is genuinely different for each person.

The NHS provides useful framing on what weight management medicines can realistically achieve when used alongside lifestyle changes, their guidance is worth reading as a baseline before drawing conclusions from social media imagery.

How to tell a genuine result from an unreliable one, and where prescription matters

Not everything shared under the Wegovy label online is authentic. Some images use photographs of other people; others document weight loss from surgery or an undisclosed combination of treatments. A few show results from medicines obtained without a valid prescription, a significant concern given that the MHRA has issued repeated warnings about counterfeit weight-loss pens circulating online, some containing harmful substitutes. You can report a suspect seller via the MHRA Yellow Card scheme.

Genuine results from legitimate treatment share a few consistent features: gradual onset, GI side effects in the early weeks (nausea and changes in appetite being most common), and a plateau as the maintenance dose is reached. The photographs that look suspiciously fast or extreme are usually one of two things: a longer timeline compressed into two panels, or not what they appear to be at all. If you're considering treatment, reading Wegovy reviews alongside before and after pictures is more practically useful than any single photograph, it sets a realistic timeline so you're not disheartened in the weeks before the medicine is properly established. For a fuller understanding of the expected pace of change, how long Wegovy takes to work is also worth reviewing before drawing any conclusions.

Wegovy is a prescription-only medicine. A clinician decides whether it's appropriate for you based on your BMI, health history and any other medicines you take, not on whether a photograph looked convincing. If you'd like to understand whether you might be eligible, checking your eligibility through a free consultation is the natural next step.